mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0012 |
1 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
0.002 |
1 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.0014 |
1 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.001 |
1 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0011 |
1 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.001 |
1 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.00068 |
1 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.00074 |
1 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.00079 |
1 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
1 |